ea0029oc1.4 | Pituitary Clinical I | ICEECE2012
Drake W.
, Stiles C.
, Bevan J.
, Steeds R.
Bromocriptine (BC) and cabergoline (CAB) are ergot-derived dopamine agonists (DAs) used for the treatment of hyperprolactinaemia. Recently, concern has been raised about a possible association between long-term DA use and cardiac valvular abnormalities. These concerns are largely derived from studies in patients with Parkinsons disease receiving higher doses (typically CAB 3 mg/day vs 0.51 mg/week for hyperprolactinaemic patients). Studies in hyperprolactinaemic pa...